Retro
Retro Biosciences develops therapies for age-related diseases, using cellular reprogramming and autophagy to extend healthy human lifespan by ten years.
Secondary Market Price
Secondary Market Price
How Retro Measures Up
To help you manage your Retro equity, Prospect has run the company through our machine learning model.
Prospect Rating
Exit Risk
Funding Stage
Series A
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Retro's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Retro Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Retro's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Retro Biosciences is a biotechnology company founded in 2020 that is developing therapies for diseases driven by the biology of aging. The company's scientific work centers on cellular reprogramming, autophagy, and plasma-inspired therapeutics, using techniques like single-cell multi-omics to understand aging mechanisms. As part of its research, Retro is collaborating with OpenAI to use AI to accelerate protein engineering and is working with the Murdoch Children's Research Institute (MCRI) to advance therapies for blood disorders. The company, headquartered in Redwood City, California, was established with $180 million in initial funding from Sam Altman in May 2022.
Looking forward, Retro Biosciences has a stated mission to add ten years to the healthy human lifespan. The company's recent activities support this goal, including a US$35 million partnership with MCRI to reprogram blood stem cells for personalized therapies. This work aims to develop preventative medicine, such as replacing a person's aging blood system. The company has also been featured in media outlets for its collaboration with OpenAI, which uses GPT-4b to reengineer key transcription factors for improved stem cell generation. According to a report from the Financial Times, initial investor Sam Altman plans to contribute more funding in the company's next series A round.
- Sam Altman
- Co-Founder, CEO Joe Betts-LaCroix
- Co-Founder, COO Matt Buckley
- Co-Founder, CSO Sheng Ding
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Retro worth joining?
Evaluating an offer from a private company like Retro involves assessing many factors, including the potential value of its equity compensation. A platform like Prospect can help you model the future value of your equity and understand its tax implications.
What should I do with my Retro stock?
Deciding what to do with private company stock, such as shares in Retro, depends on your personal financial goals and the company's performance. Tools like Prospect offer personalized strategies for exercising options, planning for taxes, and deciding when to sell.
Can you sell Retro stock?
Selling stock in a private company like Retro is often possible through secondary markets or company-approved tender offers, though it can be complex. Prospect provides tools to help you navigate tender offers and identify tax-optimal shares to sell.
How can I find the value of my Retro stock?
The value of stock in a private company like Retro is typically determined by its latest 409A valuation, recent funding rounds, or secondary market transactions. You can use a platform like Prospect, which uses predictive models and secondary market data to help project your equity's future value.
What is Retro's equity worth?
The precise worth of Retro's equity isn't public information and depends on factors like the company's valuation and your specific grant details. To understand the potential post-tax value of your holdings, you can use Prospect's financial modeling tools to forecast different scenarios.
What is Retro's stock ticker symbol?
As a private company, Retro does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Retro stock?
Selling private stock like Retro's is sometimes possible via secondary markets, while buying is typically restricted to employees or accredited investors in specific funding rounds. For employees, platforms like Prospect offer tools to help manage and sell existing equity holdings in a tax-efficient way.
What is the criteria to buy or invest in Retro stock?
Investing in a private startup like Retro is typically limited to accredited investors participating in organized funding rounds or employees receiving equity as part of their compensation. These opportunities are not generally available to the public.
